Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017–2021)

BACKGROUND: In humans, several safety evaluations have shown minimal adverse events with oral paclitaxel; however, its therapeutic efficacy and safety has not been well established in dogs with various cancers. OBJECTIVES: We aimed to retrospectively evaluate the efficacy and safety of oral paclitax...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Hyung‐Kyu, Oh, Ye‐In, Park, Sumin, An, Ju‐Hyun, Seo, Kyoungwon, Kang, Kyuyong, Chu, Seung‐nam, Youn, Hwa‐Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
DOGS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297763/
https://www.ncbi.nlm.nih.gov/pubmed/35633063
http://dx.doi.org/10.1002/vms3.829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297763/
https://www.ncbi.nlm.nih.gov/pubmed/35633063
http://dx.doi.org/10.1002/vms3.829

Ejemplares similares